Infectious Disease - HIV/Immunodeficiency News & Articles

361 New assays for monitoring residual HIV burden in effectively treated individuals Current Opinion in HIV and AIDS, April 10, 2013    Clinical Article

362 The Effects of Gay Sexually Explicit Media on the HIV Risk Behavior of Men Who Have Sex with Men AIDS and Behavior, April 10, 2013    Clinical Article

363 Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans Clinical Infectious Diseases, April 10, 2013

364 Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men European Journal of Preventive Cardiology, April 10, 2013    Clinical Article

365 HIV Treatments have Malaria Gametocyte Killing and Transmission Blocking Activity The Journal of Infectious Diseases, April 10, 2013    Clinical Article

366 A randomized Phase I bioequivalence clinical trial of a paediatric fixed-dose combination antiretroviral reconstitutable suspension in healthy adult volunteers Antiviral Therapy , April 10, 2013    Clinical Article

367 A Doubly Fluorescent HIV-1 Reporter Shows that the Majority of Integrated HIV-1 Is Latent Shortly after Infection Journal of Virology, April 10, 2013    Review Article

368 Oral mucosal status and salivary IgA levels of HIV-infected children Journal of Oral Pathology & Medicine, April 10, 2013    Clinical Article

369 HIV-associated lipodystrophy in South Africa: The impact on the patient and the impact on the plastic surgeon Journal of Plastic, Reconstructive & Aesthetic Surgery, April 10, 2013    Clinical Article

370 Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation Immunology Letters, April 10, 2013    Review Article

371 Predictors of never testing for HIV among a national online sample of men who have sex with men in Norway Scandinavian Journal of Public Health, April 10, 2013    Clinical Article

372 Marital status and HIV/AIDS mortality: evidence from the US National Longitudinal Mortality Study International Journal of Infectious Diseases, April 9, 2013    Clinical Article

373 Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS Cochrane Reviews, April 9, 2013    Clinical Article

374 Analytical performance of an automated assay quantifying HIV-1 from dried blood spots Journal of Clinical Virology, April 9, 2013    Clinical Article

375 Diffusion tensor MRI evaluation of the corona radiata, cingulate gyri, and corpus callosum in HIV patients Journal of Magnetic Resonance Imaging, April 9, 2013    Clinical Article

376 Neurocognitive function in HIV-positive children in a developing country International Journal of Infectious Diseases, April 9, 2013    Clinical Article

377 Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy, 1999-2009 HIV Medicine, April 9, 2013    Clinical Article

378 Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI) Full Text BMC Infectious Diseases, April 9, 2013    Clinical Article

379 Pruritic papular eruption in HIV: a case successfully treated with NB-UVB Dermatologic Therapy, April 9, 2013

380 Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008--2010: lessons and challenges for low-resource settings Full Text BMC Public Health, April 9, 2013    Clinical Article

1 A Conceptual Framework for Understanding Chronic Pain in Patients with HIV Pain Practice, April 5, 2013

2 The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies PLoS Medicine, March 15, 2013    Free full text    Evidence Based Medicine

3 Is Frequent CD4+ T-Lymphocyte Count Monitoring Necessary for Persons With Counts >=300 Cells/{micro}L and HIV-1 Suppression Clinical Infectious Diseases, April 11, 2013

4 Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapy Journal of Medical Economics , April 12, 2013

5 Contribution of genetic background, traditional risk factors and HIV-related factors to coronary artery disease events in HIV-positive persons Clinical Infectious Diseases, April 1, 2013

6 A Pill for HIV Prevention: Deja Vu All Over Again Clinical Infectious Diseases, March 28, 2013

7 Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK Journal of Acquired Immune Deficiency Syndromes, April 16, 2013

8 SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitibine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen Clinical Infectious Diseases, April 2, 2013

9 Faith-Based HIV Prevention and Counseling Programs: Findings from the Cincinnati Census of Religious Congregations AIDS and Behavior, April 10, 2013

10 Effects of Smoking on Non-AIDS-Related Morbidity in HIV-Infected Patients Clinical Infectious Diseases, April 29, 2013

11 Cobicistat: A New Boost for the Treatment of Human Immunodeficiency Virus Infection Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013

12 Hcv clearance from saliva of hiv-hcv coinfected patients on treatment with interferon plus ribavirin Oral Diseases , April 15, 2013    Evidence Based Medicine

13 CD4 Count Slope and Mortality in HIV-Infected Patients on Antiretroviral Therapy: Multicohort Analysis From South Africa Journal of Acquired Immune Deficiency Syndromes, April 12, 2013    Review Article

14 A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection: Analysis of Week 96 Results Journal of Acquired Immune Deficiency Syndromes, April 17, 2013

15 Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001-2009 Clinical Infectious Diseases, February 26, 2013

16 Monocyte and Myeloid Dendritic Cell Activation Occurs Throughout HIV Type 2 Infection, an Attenuated Form of HIV Disease The Journal of Infectious Diseases, April 12, 2013

17 Rilpivirine vs. efavirenz in HIV-1 patients with baseline viral load 100,000 copies/ml or less: week 48 phase III analysis AIDS, March 21, 2013

18 Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis The Lancet Infectious Diseases, April 18, 2013

19 Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs The Lancet, March 29, 2013

20 Immune control of HIV-1 reservoirs Current Opinion in HIV and AIDS, April 23, 2013